The goal of LAB150 is to develop new treatments and cures for serious and debilitating diseases. We are creating a new blueprint for translating academic research into market-ready products for the benefit of Canadians and indeed people everywhere.
Innovators who choose to work with LAB150 don’t go it alone. When we take a technology into our portfolio, we provide all of the services needed to take it from bench to commercilaization, covering every aspect of the early-stage drug discovery cycle.
Services We Provide
LAB150 helps innovators access a wide range of drug discovery and development capabilities, including:
Target Identification and Validation
Screening and Hit Identification
Testing Novel Therapeutics in In-Vivo Models
Drug Metabolism and Pharmacokinetics
Proteomics and Metabolomics
- Innovators affiliated with MI’s Member Institutions submit Statement of Interest
- MaRS Innovation and Evotec AG conduct technical, market and intellectual property due diligence
- LAB150 and Innovators collaboratively prepare project plan and budgets
- Innovators make formal presentations to the Joint Steering Committee who then make the final admission decision
- Project launch